Cafepharma Today

January 24 2024 - Novo Nordisk links next-gen obesity drug to 22% weight loss at Week 36, sending stock up 11%
Novo Nordisk links next-gen obesity drug to 22% weight loss at Week 36, sending stock up 11%
Moderna races to create norovirus vaccines
Merck, Eisai's star-crossed Keytruda-Lenvima combo misses survival goal in GI cancer trial
Trump administration delays funding to cancer research
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Forest Laboratories, Inc. Reports Q3'09 Diluted Earnings Per Share of $0.62, Including $0.41 Per Share Charge for New Product Licensing Fees
MSN Money
Tuesday, January 20, 2009 - 8:16am
tags:
Forest Labs, earnings
Cynosure Has Weak Q4, Sparking Possibilities of Takeover
Seeking Alpha
Tuesday, January 20, 2009 - 7:27am
tags:
Cynosure
J&J likely to deliver in Q4 - Earnings Preview
RTT News
Tuesday, January 20, 2009 - 7:25am
tags:
earnings, JNJ
Biogen Idec Inc. (BIIB): Zacks Rank Buy
Zacks.com
Tuesday, January 20, 2009 - 7:24am
tags:
Biogen Idec
Teva Pharmaceutical Industries, Lonza Group sign deal to make copies of biotech drugs
Yahoo/AP
Tuesday, January 20, 2009 - 7:23am
tags:
biotech, Teva Pharmaceuticals, Lonza, Merck, generics
Genentech in 2009
Zachs.com
Monday, January 19, 2009 - 11:01am
tags:
Genentech
Looking for the Biotech Breakout
Seeking Alpha
Monday, January 19, 2009 - 9:13am
tags:
biotech, Biotech Ishares, Anadys, Cypress Bioscience, CV Therapeutics, Valeant Pharmaceuticals, Illumina, Biogen Idec, Life Technologies, Sequenom, Biomarin
Galapagos and GlaxoSmithKline Expand Anti-Infectives Alliance
CNN Money
Monday, January 19, 2009 - 9:10am
tags:
Galapagos, GSK, anti-infectives
FDA fails to meet Takeda drug application deadline
Hays Pharma, UK
Monday, January 19, 2009 - 9:08am
tags:
FDA, Takeda, febuxostat
CSL-Talecris Antitrust Probe to Take Months, UBS Says
Bloomberg
Monday, January 19, 2009 - 9:06am
tags:
CSL, Talecris, buyouts
Even Pfizer Has Fallen Upon Some Hard Times
The Day, CT
Sunday, January 18, 2009 - 12:10pm
tags:
Pfizer
China Biopharma Continues to Expand Offerings
Seeking Alpha
Sunday, January 18, 2009 - 12:05pm
tags:
China, biotech
Lundbeck may have revived its interest in Elan
Irish Independent, Ireland
Sunday, January 18, 2009 - 12:04pm
tags:
Elan, Lundbeck
WuXi Gains From Pfizer's Loss
Seeking Alpha
Sunday, January 18, 2009 - 11:15am
tags:
WuXi PharmaTech, Pfizer
Perspective on Pfizer Layoffs
Seeking Alpha
Sunday, January 18, 2009 - 11:14am
tags:
Pfizer
'Pharma industry (in India) not impacted by global slowdown'
The Hindu, India
Saturday, January 17, 2009 - 9:18am
tags:
India
Warner Chilcott files suit to protect Doryx patent
MSNBC
Saturday, January 17, 2009 - 9:16am
tags:
Warner Chilcott, DORYX
Cornerstone Biopharma steps into ring with Merck, AstraZeneca
Triangle Business Journal, NC
Saturday, January 17, 2009 - 9:14am
tags:
Cornerstone Therapeutics, Merck, AstraZeneca, asthma
New drug for treatment of acne
MSNBC
Saturday, January 17, 2009 - 9:13am
tags:
acne
Peptimmune, Novartis Sign $500M Deal for MS Drug
Bioworld
Saturday, January 17, 2009 - 9:12am
tags:
PeptImmune, Novartis, MS, multiple sclerosis

Pages

Latest CP Wire Articles

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Latest Pharmagather Articles

New Study Reveals Five Crucial Priorities Shaping The Future of Patient Services
Drug Channels
Killing Cancer Patients (Once the Payments Clear)
In the Pipeline
The Big Three PBMs’ 2025 Formulary Exclusions: Humira, Stelara, Private Labels, and the Shaky Future for Pharmacy Biosimilars
Drug Channels
Clinical Trial Readouts Are A-Comin'
In the Pipeline
The Current Environment
In the Pipeline
Informa Connect's Patient Assistance & Access Programs (PAP)
Drug Channels
2025 Brand Drug Challenges: A GoodRx Perspective
Drug Channels
Snake Antivenoms, Computed
In the Pipeline
Versatile Chaperones
In the Pipeline

Latest Jobs

Onsite Endoscopic Specialist - Operating Room Support
Santa Monica, California
KARL STORZ Endoscopy - America
Area Manager, Immunology Rochester, NY Territory
Fields, Oregon, 97710
CSL Behring
Psychiatry Account Manager - Tarrytown, NY
Tarrytown, New York
Lundbeck
Area Manager Specialty, West- Central
Fields, Oregon, 97710
CSL Behring
Area Sale Manager, Immunology Tampa North
Fields, Oregon, 97710
CSL Behring
Sales Representative
Boise, Idaho, 83708
Bartlett Roofing
Capital Project Manager
Carteret, New Jersey, United States
The Spear Group
Area Manager Specialty, West
Fields, Oregon, 97710
CSL Behring
Psychiatry Account Manager - Midland, TX
Midland, Texas, 79701
Lundbeck
Home Health and Medical Sales
The Woodlands, Texas, 77381
Comfort Keepers of Dallas TX
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information